Last Updated: November 9, 2026

CLINICAL TRIALS PROFILE FOR ARGATROBAN IN DEXTROSE

« Back to Dashboard

All Clinical Trials for ARGATROBAN IN DEXTROSE

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00035178 ↗	Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis	Completed	Texas Biotechnology Corporation	Phase 4	2002-05-01	The primary goals of this investigation are to provide guidance on how to dose Argatroban in patients undergoing hemodialysis and to assess the safety and tolerability of Argatroban in hemodialysis patients. The secondary goal of the study will be to assess the adequacy of anticoagulation during hemodialysis.
NCT00039858 ↗	Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin	Completed	GlaxoSmithKline	Phase 4	2003-09-01	The purpose of this study is to evaluate the safe and effective dose of Argatroban for prophylaxis and/or treatment of thrombosis in pediatric patients with current or previous diagnosis of heparin-induced thrombocytopenia (HIT) and thrombosis syndrome (HITTS), or who in the opinion of the investigator require alternative anticoagulation due to an underlying condition.
NCT00039858 ↗	Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin	Completed	Encysive Pharmaceuticals	Phase 4	2003-09-01	The purpose of this study is to evaluate the safe and effective dose of Argatroban for prophylaxis and/or treatment of thrombosis in pediatric patients with current or previous diagnosis of heparin-induced thrombocytopenia (HIT) and thrombosis syndrome (HITTS), or who in the opinion of the investigator require alternative anticoagulation due to an underlying condition.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ARGATROBAN IN DEXTROSE

Condition Name

Chart
Table

Condition Name for ARGATROBAN IN DEXTROSE
Intervention	Trials
Heparin-induced Thrombocytopenia	4
Stroke	3
Ischemic Stroke	3
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ARGATROBAN IN DEXTROSE
Intervention	Trials
Thrombocytopenia	10
Stroke	9
Ischemic Stroke	7
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ARGATROBAN IN DEXTROSE

Trials by Country

Map
Table

Trials by Country for ARGATROBAN IN DEXTROSE
Location	Trials
United States	75
Japan	12
China	10
Germany	9
France	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ARGATROBAN IN DEXTROSE
Location	Trials
Texas	6
Ohio	4
Massachusetts	4
Minnesota	4
Illinois	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ARGATROBAN IN DEXTROSE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ARGATROBAN IN DEXTROSE
Clinical Trial Phase	Trials
PHASE4	1
Phase 4	15
Phase 3	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ARGATROBAN IN DEXTROSE
Clinical Trial Phase	Trials
Completed	18
Recruiting	9
Terminated	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ARGATROBAN IN DEXTROSE

Sponsor Name

Chart
Table

Sponsor Name for ARGATROBAN IN DEXTROSE
Sponsor	Trials
Mitsubishi Tanabe Pharma Corporation	3
The University of Texas Health Science Center, Houston	3
GlaxoSmithKline	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ARGATROBAN IN DEXTROSE
Sponsor	Trials
Other	28
Industry	15
NIH	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.